10-Q: Phreesia Inc. Reports 17% Revenue Growth in Q3 2025, Despite Payment Processing Headwinds

Phreesia Inc. saw a 17% increase in total revenue for the third quarter of fiscal year 2025, reaching $106.8 million, despite challenges in payment processing.

Summary

• Phreesia Inc. reported a 17% increase in total revenue to $106.8 million for the three months ended October 31, 2024, compared to $91.6 million for the same period in 2023.
• The company's net loss was $14.4 million for the quarter, a significant improvement from the $31.9 million loss in the same quarter of the previous year.
• Adjusted EBITDA for the quarter was $9.8 million, a substantial turnaround from a negative $6.6 million in the prior year's comparable quarter.
• For the nine months ended October 31, 2024, total revenue increased by 19% to $310.1 million, compared to $261.3 million in the same period of 2023.
• The net loss for the nine-month period was $52.1 million, a considerable improvement from the $106.2 million loss in the same period of the previous year.
• Adjusted EBITDA for the nine-month period was $20.4 million, compared to a negative $31.9 million in the same period of the previous year.
• The company experienced a decrease in cash and cash equivalents by $5.8 million since January 31, 2024, ending at $81.7 million as of October 31, 2024.
• Payment processing revenue was impacted by the Change Healthcare cyber incident, reducing revenue by approximately $1.4 million in the third quarter of fiscal 2025.
• The company's average number of healthcare services clients (AHSCs) was 4,237 for the quarter, up from 3,688 in the same period last year.
• Healthcare services revenue per AHSC was $17,481 for the quarter, a slight decrease from $17,845 in the same period last year.
• Total revenue per AHSC was $25,207 for the quarter, a slight increase from $24,842 in the same period last year.

Sentiment

Score: 7

Explanation: The document shows positive trends in revenue growth and profitability, but also highlights challenges related to cybersecurity and payment processing. The overall sentiment is cautiously optimistic.

Positives

• The company experienced a significant improvement in net loss and adjusted EBITDA compared to the same periods in the previous year.
• Subscription and related services revenue increased by 16% in Q3 2025, driven by new clients and expansion within existing clients.
• Network solutions revenue saw a substantial increase of 27% in Q3 2025, indicating strong growth in this segment.
• The company's cash flow from operations turned positive in Q3 2025, reaching $5.8 million.
• The company's free cash flow also turned positive in Q3 2025, reaching $1.6 million.
• The company's average number of healthcare services clients (AHSCs) increased to 4,237 in Q3 2025, indicating continued growth in its client base.

Negatives

• Payment processing revenue growth was limited to 6% in Q3 2025, impacted by the Change Healthcare cyber incident and the wind-down of a clearinghouse relationship.
• Healthcare services revenue per AHSC decreased slightly by 2% in Q3 2025, indicating a potential need to focus on increasing revenue per client.
• The company's cash and cash equivalents decreased by $5.8 million since January 31, 2024, ending at $81.7 million as of October 31, 2024.
• The company experienced a service disruption to the ConnectOnCall service due to a cybercriminal gaining access, which remains partially offline.

Risks

• The company faces risks related to managing rapid growth, competition, and fluctuations in operating results.
• Cybersecurity incidents, such as the Change Healthcare and ConnectOnCall incidents, pose a significant risk to the company's operations and reputation.
• The company's reliance on third-party vendors and partners, including those in international locations, exposes it to operational and financial risks.
• The company's variable sales and implementation cycles may lead to fluctuations in quarterly results.
• The company's estimates of its target market size may be inaccurate, and its growth may not match market growth.
• The company depends on key personnel, and the loss of such personnel could adversely affect its business.
• The company's operations in India are subject to additional risks, including wage increases and political instability.
• The company is subject to various healthcare laws and data privacy regulations, which may impose restrictions and penalties.
• The company's reliance on a limited number of clients for a substantial portion of its revenue poses a risk to its financial stability.
• The company's ability to use its net operating losses to offset future taxable income may be subject to certain limitations.

Future Outlook

Management believes that the company's cash and cash equivalents, along with cash generated in the normal course of business and available borrowing capacity under its revolving credit facility, are sufficient to fund its operations for at least the next 12 months. The company may seek to obtain additional financing, if needed, to successfully implement its long-term strategy.

Management Comments

• Management believes that net losses and negative cash flows will continue for at least the next year.
• Management believes that the company's cash and cash equivalents at October 31, 2024, along with cash generated in the normal course of business and available borrowing capacity under its revolving credit facility with Capital One, are sufficient to fund its operations for at least the next 12 months.
• The company may seek to obtain additional financing, if needed, to successfully implement its long-term strategy.

Industry Context

The company operates in a competitive and rapidly evolving healthcare technology market. The results reflect the company's ability to grow its client base and expand its service offerings, while also navigating challenges such as cybersecurity incidents and changes in the payment processing landscape. The company's focus on patient engagement and communication aligns with broader industry trends towards patient-centered care.

Comparison to Industry Standards

• Phreesia's revenue growth of 17% in Q3 2025 is strong compared to the average growth rate of the healthcare technology sector, which is estimated to be around 10-15% annually. Companies like Veeva Systems and athenahealth, which also operate in the healthcare SaaS space, have reported similar growth rates in recent quarters, but Phreesia's growth is notable given the headwinds in payment processing.
• The improvement in Phreesia's net loss and adjusted EBITDA is a positive sign, as many healthcare technology companies are still focused on growth over profitability. Companies like Teladoc Health and Livongo (now part of Teladoc) have struggled with profitability, while Phreesia's move towards positive adjusted EBITDA is a positive sign.
• Phreesia's average number of healthcare services clients (AHSCs) of 4,237 is a good indicator of its market penetration, but it is still smaller than some of the larger players in the industry. Companies like Epic Systems and Cerner have a much larger client base, but Phreesia's focus on patient engagement and communication gives it a unique value proposition.
• The impact of the Change Healthcare cyber incident on Phreesia's payment processing revenue highlights the risks associated with relying on third-party vendors. This is a common challenge in the healthcare industry, and companies are increasingly focusing on building more resilient and secure systems.
• Phreesia's free cash flow of $1.6 million in Q3 2025 is a positive sign, as many healthcare technology companies are still burning cash. This indicates that Phreesia is becoming more efficient in its operations and is generating more cash from its business.

Related Party Transactions

• The Company recognized revenue totaling $326 and $997 for the three and nine months ended October 31, 2024, respectively, for advertisements placed by a pharmaceutical company where one of the Company's independent board members serves on the board of directors.

Stakeholder Impact

• Shareholders will be impacted by the company's financial performance and any changes in the stock price.
• Employees may be affected by changes in the company's operations and financial performance.
• Customers may be impacted by the company's ability to provide reliable and secure services.
• Suppliers and creditors may be affected by the company's financial stability and ability to meet its obligations.

Next Steps

• The company will continue to monitor the situation regarding new developments related to the Change Healthcare cybersecurity incident.
• The company is working diligently to restore the remainder of the ConnectOnCall service.
• The company will continue to evaluate its investment policy to ensure it meets its overall objectives.
• The company plans to adopt ASU 2023-07 for annual periods beginning in the fiscal year ending January 31, 2025 and for interim periods beginning in the fiscal year ending January 31, 2026.
• The company plans to adopt ASU 2023-09 for annual periods beginning in the fiscal year ending January 31, 2026.
• The company plans to adopt ASU 2024-03 for annual periods beginning in the fiscal year ending January 31, 2028 and for interim periods beginning in the fiscal year ending January 31, 2029.

Key Dates

Keywords

SaaS, healthcare, patient engagement, payment processing, network solutions, cybersecurity, HIPAA, EHR, revenue growth, financial results